Douglas S. Ingram, President & CEO at Sarepta Therapeutics, Inc. (SRPT), bought 76,276 shares at $52.44 ($4.0M) on 2017-11-08, disclosed to the SEC on 2017-11-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.44 | 38,138 | $2.0M | 50.0% |
| 2 | $52.44 | 38,138 | $2.0M | 50.0% |
| Total | $52.44 avg | 76,276 | $4.0M | 100% |
| Filing → |
| RLAY | BUY | 2020-07-21 | $500K | — | Filing → |
| SRPT | BUY | 2019-08-12 | $4.0M | — | Filing → |
| SRPT | BUY | 2018-10-30 | $4.0M | — | Filing → |